You are here: Home > Institute of Excellence (CPD) > CPD Events > PDR: A New Anti-VEGF Era?

PDR: A New Anti-VEGF Era?

Available from: 11/12/2018

Where to publish: and

Provider: Mivision

Contact: Nikki Byrne, [E], [P] 02 8336 8616

Learning Objectives

  • How to diagnose proliferative diabetic retinopathy
  • The prevalence and epidemiology of proliferative diabetic retinopathy
  • The risk factors for proliferative diabetic retinopathy
  • The clinical features of proliferative diabetic retinopathy and that this is an eye-threatening disease
  • Ocular and systemic investigations required for proliferative diabetic retinopathy. Ocular investigations to be discussed include: optical coherence tomography, fluorescein angiography and OCT-angiography.
  • That both ocular and systemic management is required for the treatment of proliferative diabetic retinopathy. That the mainstay of ocular management is panretinal photocoagulation, although intra-vitreal anti-VEGF therapy may also have a role.
  • The indications for performing vitrectomy surgery in patients with proliferative diabetic retinopathy

Max points awarded: 2.00

Session Information

PDR: A New Anti-VEGF Era?
Activity Type
Independent Learning with Assessment
Points for attending & Passing Assessment

NameActivity TypeTherapeutic?Manufacturer/
Points for attending &
Passing Assessment
PDR: A New Anti-VEGF Era?Independent Learning with AssessmentNoNo2.00

Acknowledgement of Country

In the spirit of reconciliation Optometry Australia acknowledges the Traditional Custodians of country throughout Australia and their connections to land, sea and community. We pay our respects to their Elders past and present and extend that respect to all Aboriginal and Torres Strait Islander peoples today.